BackNatureWise Biotech & Medicals Overview

NatureWise Biotech & Medicals Current Assets

Latest current assets for 4732.TWO: $580M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$577.43M
↓ 19.79% YoYΔ $-142.50M vs prior year quarter

Peer trimmed avg / median

Loading

NatureWise Biotech & Medicals Current Assets History

Loading

NatureWise Biotech & Medicals vs. peers: Current Assets Comparison

Loading

NatureWise Biotech & Medicals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

NatureWise Biotech & Medicals (4732.TWO) FAQ

The latest current assets for 4732.TWO is $580M as of June 2026. That compares with $720M in the prior-year period — down 19.8% year over year. Investors often review this figure alongside NatureWise Biotech & Medicals's historical trend and sector peers before judging valuation or financial health.

Over the past year, 4732.TWO's current assets moved from $720M to $580M — a 19.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NatureWise Biotech & Medicals's operating scale or balance-sheet position.

A current assets figure of $580M for 4732.TWO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 4732.TWO's current assets ($580M), review year-over-year change from $720M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack NatureWise Biotech & Medicals's current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.